You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Covid-19 - Resource center

Medizinische Fachkräfte finden Hilfe und Orientierung, wie sie unsere Angebote zur Behandlung Ihrer Patienten nutzen können. Zusätzlich erhalten Sie weitere praktische Informationen und Ratschläge.

Erfahren Sie mehr

ISICEM 2020

40th International Symposium on Intensive Care and Emergency Medicine - postponed to September 2020

Brussels, Belgium September 1 - 2, 2020

This year is the 40th edition of the ISICEM congress: over the years, the congress has become a reference within the intensive care medicine world and is a must attend event for more than 6,000 participants.

Please notice: In view of the current situation, the 40th ISICEM has been postponed by 6 months and will take place in September 2020.

Veranstaltungsdaten

Datum: September 1 - 2, 2020
Stadt: Brussels, Belgium
Veranstaltungsort: Square - Brussels Convention Center
Stand: 2.32 - 2.35

Website der Veranstaltung anzeigen

Getinge symposium

Getinge lunch symposia

Getinge will also take part to the scientific program of the event by offering two sponsored lunch symposia to the congress attendees on Wednesday, September 16 and Thursday, September 17 from 12:30 to 13:30.

Advanced technologies to manage severe patients

Date: Wednesday, September 16, 2020 
Time: 12:30 – 13:30
Venue: Silver Hall

Chairperson: Fernando Suarez Sipmann (Madrid, Spain)

  • Lung recruitment: can automation and enhanced monitoring improve safety and efficacy?
    Fernando Suarez Sipmann (Madrid, Spain)
  • Avoidance of fluid overload
    Manu Malbrain (Brussels, Belgium)
  • ECMO for acute myocardial infarction cardiogenic shock: the ANCHOR trial
    Alain Combes (Paris, France)

Challenges and solutions in the treatment of COPD patients

Date: Thursday, September 17, 2020 

Time: 12:30 – 13:30
Venue: Silver Hall

Chairperson: Ewan Goligher (Toronto, Canada)

  • NIV NAVA: Monitoring effort and enhancing synchrony to avoid intubation
    Ewan Goligher (Toronto, Canada)
  • Can transpulmonary thermodilution benefit COPD patients during weaning?
    Xavier Monnet (Paris, France)
  • CO2 removal for COPD patients
    Marco Ranieri (Bologna, Italy)

Simulation center 2020

We are excited to offer you the chance to take part in an interactive, hands-on learning experience in the Simulation center.

  • Presentation and interactive discussion of a challenging case from one of three clinical scenarios: Septic shock, ARDS, use of ECMO
  • Hands-on experience of monitoring devices relevant to each clinical scenario
  • Critical appraisal of therapeutic strategies relevant to each clinical scenario
  • Consideration of how to individualize therapy in light of results from large RCTs

Each Session will last 45 minutes and include 1 case presenter, 1 expert and a maximum of 10 participants.

View the Simulation center schedule here

PulsioFlex Monitor

Modulare Plattform mit intelligenter Visualisierung für das erweiterte Patientenmonitoring

Mehr erfahren über PulsioFlex Monitor

Early Protective Mechanical Ventilation is key to ARDS outcomes

The Lungsafe study demonstrated that protective ventilation is not consistently applied, reflecting the need for more accessible and effective bedside tools for identification of the lung at risk [1]. This important study concluded that ARDS is underrecognized, undertreated, and still associated with a high mortality rate.

Mehr erfahren über ARDS - Mechanical Ventilation

ECLS can be a life-saver for ARDS patients

Despite advances in treatment options, mortality and morbidity in patients with acute respiratory distress syndrome (ARDS) remain high. Extracorporeal membrane oxygenation (ECMO) has emerged as a promising intervention. [1] Improvements in technology have made ECMO safer and easier to use, allowing for the potential of more patients with ARDS receiving this therapy.

Mehr erfahren über ECMO for ARDS

NICCI Technologie

NICCI ist die jüngste Innovation für erweitertes hämodynamisches Monitoring und liefert nichtinvasiv kontinuierliche Werte. NICCI unterstützt individuelle Handlungsentscheidungen durch zuverlässige, dynamische Parameter wie mittlerem arteriellen Druck (MAP), Herzindex (HI), Schlagvolumenvariation (SVV) und Pulsdruckvariation (PPV). *Die Verfügbarkeit von NICCI ist abhängig von der behördlichen Zulassung in Ihrer Region.

Mehr erfahren über NICCI Technologie